| Pharmaceutical Pipelines Pharmaceuticals_and_biotechnology > Reference > Pharmaceutical Pipelines |  |
NeoTherapeutics’ patented process for creating the AIT series of synthetic compounds.
ViraZyme Technology based product pipeline.
HGS has developed a Functional Genomics Program that begins with the discovery of new human genes and extends through human clinical trials.
Drug candidates and R&D approach, areas of R&D.
Genetics Institute, Inc., is developing a portfolio of proprietary products including blood cell growth factors, bone-inducing proteins, and agents to treat cancer, infectious disease and hemophilia
Our pipeline includes two cancer drug candidates in clinical testing, one cancer drug candidate for which an Investigational New Drug application has been approved, one preclinical cytomegalovirus drug candidate and 14 drug leads in our other pr.
Cortex believes that increasing AMPA receptor activity with AMPAKINEs will provide a new approach to treating a number of central nervous system disorders
OSI Pharmaceuticals is a Pharmaceutical Research and Development Organization (PRDO) that utilizes a high tech, comprehensive drug discovery and development capability to rapidly and cost effectively discover and develop novel, small molecule dr.
Amgen Marketed Products and Pipeline Candidates
Vaccine products pipeline
Genetix Pharmaceuticals' research effort is concentrated on improved gene transfer systems. Current projects are aimed at efficient and permanent transduction of non-dividing cells in both in vivo and ex vivo settings.
New Drugs provides a timely profile of all pharmaceutical substances designed for the United States market.
Product portfolio in development, and marketed products.
Axys Pharmaceuticals has developed a broad pipeline of small molecule drugs to treat significant diseases, including asthma, blood clotting disorders, arthritis, osteoporosis, cancer, and inflammatory and infectious diseases.
Pipeline consisting of antiviral, cancer, automimmune & inflammation, neurological disorders.
Medco Research is dedicated to being a leader in the global commercialization of cardiovascular medicines and adenosine-based products leading to superior growth in shareholder value.
Amylin Pharmaceuticals, Inc. is a development pharmaceutical company focused on metabolic disorders, and specializing in preclinical characterization of lead molecules and demonstration of proof of principle in humans.
Our research focuses on developing compounds in five key areas: infectious diseases, neurological and urological diseases, immunologic diseases, metabolic diseases, and cancer.
Research and clinical development table of products in the pipeline.
Gastrointestinal, Pain & Endocrine,HIV, Infectious Diseases & Hepatitis, Metabolic, Cardiovascular Risk Factors & Oncology, Neurology & Psychiatry, Respiratory Disease
| Nb of links = 20 |